Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials - This next-generation anthracycline demonstrates safety and promising early activity in treating multiple ...
Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1 ...
“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback